# Comparison of Voice Therapy and Antireflex Therapy in LPR

> **NCT02530879** · PHASE4 · WITHDRAWN · sponsor: **Temple University**

## Conditions studied

- Laryngopharyngeal Reflux

## Interventions

- **DRUG:** Omeprazole, Lansoprazole, Esomeprazole, Rantidine
- **BEHAVIORAL:** Voice therapy
- **OTHER:** Combination of anti-reflux medication and voice therapy

## Key facts

- **NCT ID:** NCT02530879
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-05
- **Primary completion:** 2017-08
- **Final completion:** 2018-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inability to recruit patients
- **Last updated:** 2018-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02530879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02530879, "Comparison of Voice Therapy and Antireflex Therapy in LPR". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02530879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
